MedDataX Logo

Optimal Length of Pre-inserted ETT for Nasal Fiber Optic Intubation

NCT ID: NCT02016144

Last Updated: 2013-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-10-31

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is intended to find the optimal length of pre-inserted ETT for nasal fiberoptic intubation and the equation to predict it.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasal Fiberoptic Intubation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Airway management; Fiber optic technology; Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA physical status I-II
* aged 20-65 yr (adults)

Exclusion Criteria

* rhinitis
* bleeding diatheses
* requirement of awake intubation
* a previous major oral and maxillofacial surgery history
* anatomical deformity of the face, neck and upper airway
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Dental Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jung-Man Lee

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jung-Man Lee, M.D

Role: PRINCIPAL_INVESTIGATOR

Seoul National University Dental Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Dental Hospital

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JLee_optimal_length

Identifier Type: -

Identifier Source: org_study_id